Literature DB >> 10817652

Haplotype-phenotype correlation in Fukuyama congenital muscular dystrophy.

K Saito1, M Osawa, Z P Wang, K Ikeya, Y Fukuyama, E Kondo-Iida, T Toda, H Ohashi, K Kurosawa, S Wakai, K Kaneko.   

Abstract

In typical Fukuyama congenital muscular dystrophy (FCMD), peak motor function is usually only unassisted sitting or sliding on the buttocks, though a few patients are able to walk at some point. However, a few patients have a severe phenotype and never acquire head control. In addition, it is clinically difficult to differentiate this severe FCMD from Walker-Warburg syndrome (WWS) or from muscle-eye-brain disease (MEBD). In order to establish a genotype-phenotype correlation, we performed haplotype analysis using microsatellite markers closest to the FCMD gene (FCMD) in 56 Japanese FCMD families, including 35 families whose children were diagnosed as FCMD with the typical phenotype, 12 families with a mild phenotype, and 9 families with a severe phenotype. Of the 12 propositi with the mild phenotype, 8 could walk and the other 4 could stand with support; 10 cases were homozygous for the ancestral founder (A-F) haplotype whereas the other 2 were heterozygous for the haplotype. In the 9 severe cases, who had never acquired head control or the ability to sit without support, 3 had progressive hydrocephalus, 2 required a shunt operation, and 7 had ophthalmological abnormalities. Haplotype analysis showed that 8 of the 9 cases of the severe phenotype are heterozygous for the A-F haplotype, and the other one homozygous for the haplotype. We confirmed that at least one chromosome in each of the 56 FCMD patients has the A-F haplotype. The rate of heterozygosity for the A-F haplotypes was significantly higher in severe cases than in typical or mild cases (P < 0.005). Severe FCMD patients appeared to be compound heterozygotes for the founder mutation and another mutation. Thus, the present study yielded molecular genetic evidence of a broad clinical spectrum in FCMD.

Entities:  

Mesh:

Year:  2000        PMID: 10817652     DOI: 10.1002/(sici)1096-8628(20000529)92:3<184::aid-ajmg5>3.0.co;2-n

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  5 in total

Review 1.  The congenital muscular dystrophies: recent advances and molecular insights.

Authors:  Jerry R Mendell; Daniel R Boué; Paul T Martin
Journal:  Pediatr Dev Pathol       Date:  2006 Nov-Dec

2.  Target resequencing of neuromuscular disease-related genes using next-generation sequencing for patients with undiagnosed early-onset neuromuscular disorders.

Authors:  Yuri Kitamura; Eri Kondo; Mari Urano; Ryoko Aoki; Kayoko Saito
Journal:  J Hum Genet       Date:  2016-06-30       Impact factor: 3.172

3.  Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation.

Authors:  Rebecca L Puckett; Steven A Moore; Thomas L Winder; Tobias Willer; Stephen G Romansky; Kelly King Covault; Kevin P Campbell; Jose E Abdenur
Journal:  Neuromuscul Disord       Date:  2009-04-01       Impact factor: 4.296

4.  Experimental method for haplotype phasing across the entire length of chromosome 21 in trisomy 21 cells using a chromosome elimination technique.

Authors:  Sachiko Wakita; Mari Hara; Yasuji Kitabatake; Keiji Kawatani; Hiroki Kurahashi; Ryotaro Hashizume
Journal:  J Hum Genet       Date:  2022-05-31       Impact factor: 3.755

Review 5.  The role of defective glycosylation in congenital muscular dystrophy.

Authors:  Harry Schachter; Jiri Vajsar; Wenli Zhang
Journal:  Glycoconj J       Date:  2004       Impact factor: 3.009

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.